
Articles
-
5 days ago |
canadianhealthcarenetwork.ca | Anaïs Bouitcha
Which is the best analgesic to treat acute pain in children? A large meta-analysis reviewed the benefits and risks associated with various treatments used for pediatric pain. One class of drugs stands out in particular. Register for free access or login. Canadian Healthcare Network is an independent online community for Canadian healthcare professionals in medicine and pharmacy. It is the online home of the Medical Post and Pharmacy Practice + Business.
-
5 days ago |
canadianhealthcarenetwork.ca | Anaïs Bouitcha
Quebec pharmacists launch first ‘day without replacements’ Calling it an ‘intolerable’ situation, the AQPP is drawing attention to the growing stranglehold of replacement agencies on the pharmacy workforce. Register for free access or login. Canadian Healthcare Network is an independent online community for Canadian healthcare professionals in medicine and pharmacy. It is the online home of the Medical Post and Pharmacy Practice + Business.
-
3 weeks ago |
professionsante.ca | Anaïs Bouitcha
La pharmacie québécoise fait front commun à l’aube du PL67 Les 5 et 6 juin se tient, à Québec, l'Événement des pharmaciennes et pharmaciens 2025. L'occasion pour les représentants de la profession de porter un même message de collaboration et d'entraide. Pour accéder au contenu, connectez-vous ou créez un compte gratuit.
-
3 weeks ago |
canadianhealthcarenetwork.ca | Anaïs Bouitcha
When you can't just cover your ears: Protecting yourself from harmful noise in your pharmacy There are many sources of noise pollution in the pharmacy, and they can make it difficult for staff to concentrate. It can even lead to burnout. But is noise inevitable? Register for free access or login. Canadian Healthcare Network is an independent online community for Canadian healthcare professionals in medicine and pharmacy. It is the online home of the Medical Post and Pharmacy Practice + Business.
-
3 weeks ago |
professionsante.ca | Anaïs Bouitcha
Traiter la dépression en même temps que la migraine D’après un nouvel essai de phase IV, le frémanezumab serait efficace et sécuritaire pour traiter à la fois la migraine et les symptômes dépressifs chez les personnes souffrant de ces deux affections comorbides. Pour accéder au contenu, connectez-vous ou créez un compte gratuit.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →